Authors' Reply

J Am Soc Nephrol. 2018 Oct;29(10):2602-2603. doi: 10.1681/ASN.2018060612. Epub 2018 Jul 13.

Authors

William G Herrington^{1

2}, Killian Donovan³, Borislava Mihaylova⁴

Affiliations

¹ Clinical Trial Service Unit and Epidemiological Studies Unit, [email protected].
² Medical Research Council Population Health Research Unit, and.
³ Clinical Trial Service Unit and Epidemiological Studies Unit.
⁴ Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

No abstract available

Keywords: Epidemiology and outcomes; FGF-23; cardiovascular.

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases*
Fibroblast Growth Factor-23
Humans
Renal Insufficiency, Chronic*

Grants and funding

MR/R007764/1/MRC_/Medical Research Council/United Kingdom